GeneDx Holdings Corp.

Casdin Life Sciences Acquisition Corp. (Nasdaq: CMLF), sponsored by Casdin Capital, filed an 8-K with the SEC on July 22, 2021, under the entity name GeneDx Holdings Corp., reflecting the genomic diagnostics and life sciences sector focus that defined the vehicle's acquisition mandate. The blank-check company completed its IPO in 2020 and targeted opportunities at the intersection of genomics and clinical data, a thesis consistent with Casdin Capital's broader life sciences investment strategy. The filing, carrying accession number 0001213900-21-037979, marks a notable point in the SPAC's corporate timeline. For complete filings history, deal timelines, and sponsor analytics on CMLF and thousands of other SPACs, sign up for full data access at SpacDesk.